FRA:FRE - Fresenius SE & Co KGaA Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started €49.88 +0.35 (+0.71 %) (As of 04/26/2019 03:42 AM ET)Previous Close€49.53Today's Range€49.78 - €50.1652-Week Range€60.16 - €80.00Volume89,578 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure. This segment offers dialyzers, dialysis machines, and renal pharmaceuticals, as well as dialysis- related services. The Fresenius Kabi segment specializes in the therapy and care of chronically and critically ill patients. This segment offers IV drugs comprising intravenously administered generic anesthetics, analgesics, anti-infectives, and drugs for the treatment of oncological and other critical diseases; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; infusion and nutrition pumps, as well as consumables; and products used in the collection and processing whole blood and blood components, as well as in transfusion medicine. The Fresenius Helios segment operates approximately 112 hospitals, including 88 acute care hospitals and 24 post-acute care clinics; 78 outpatient clinics; 4 out-patient post-acute care centers; 18 prevention centers; and 13 nursing homes. This segment has approximately 35,000 beds. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project development, planning, and turnkey construction services, as well as provides maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg, Germany. Receive FRE News and Ratings via Email Sign-up to receive the latest news and ratings for FRE and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange FRA Industry N/A Sub-IndustryN/A SectorN/A Current SymbolFRA:FRE Previous Symbol CUSIPN/A CIKN/A Webwww.fresenius.de Phone+49-6172-6080Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Fresenius SE & Co KGaA (FRA:FRE) Frequently Asked Questions What is Fresenius SE & Co KGaA's stock symbol? Fresenius SE & Co KGaA trades on the FRA under the ticker symbol "FRE." What price target have analysts set for FRE? 20 analysts have issued 12-month target prices for Fresenius SE & Co KGaA's stock. Their predictions range from €45.00 to €78.00. On average, they anticipate Fresenius SE & Co KGaA's stock price to reach €59.18 in the next twelve months. This suggests a possible upside of 19.5% from the stock's current price. View Analyst Price Targets for Fresenius SE & Co KGaA. What is the consensus analysts' recommendation for Fresenius SE & Co KGaA? 20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius SE & Co KGaA in the last year. There are currently 10 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Fresenius SE & Co KGaA. Has Fresenius SE & Co KGaA been receiving favorable news coverage? News stories about FRE stock have trended somewhat negative recently, InfoTrie Sentiment reports. The research firm scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Fresenius SE & Co KGaA earned a news sentiment score of -1.1 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. What other stocks do shareholders of Fresenius SE & Co KGaA own? Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius SE & Co KGaA investors own include Illumina (ILMN), Endologix (ELGX), Daimler (DAI), Cambrex (CBM), General Electric (GE), Linde (LIN), Rio Tinto (RIO), Apache (APA), HeidelbergCement (HEI) and Allianz (ALV). Who are Fresenius SE & Co KGaA's key executives? Fresenius SE & Co KGaA's management team includes the folowing people: Gerd Krick, Chairman of the Supervisory BoardStephan Sturm, Chief Executive Officer (Age 52)Niko Stumpfoegger, Deputy Chairman of the Supervisory Board, Employee RepresentativeJuergen Goetz, Chief Legal and Compliance Officer, Labor Relations Director, Member of the Management BoardFrancesco De Meo, Member of the Management Board, Chief Executive Officer of Fresenius HeliosMats Christer Henriksson, Member of the Management Board, Chief Executive Officer Fresenius KabiRice Powell, Member of the Management Board, Chief Executive Officer of Fresenius Medical Care (Age 61)Ernst Wastler, Member of the Management Board, Chief Executive Officer Fresenius VamedD. Michael Albrecht, Member of the Supervisory BoardMichael Diekmann, Member of the Supervisory Board (Age 63) What is Fresenius SE & Co KGaA's stock price today? One share of FRE stock can currently be purchased for approximately €49.53. What is Fresenius SE & Co KGaA's official website? The official website for Fresenius SE & Co KGaA is http://www.fresenius.de/. How can I contact Fresenius SE & Co KGaA? Fresenius SE & Co KGaA's mailing address is Else-Kroener-Str. 1, BAD HOMBURG VOR DER HOEHE, 61352, Germany. The company can be reached via phone at +49-6172-6080. MarketBeat Community Rating for Fresenius SE & Co KGaA (FRA FRE)Community Ranking: 3.1 out of 5 ( )Outperform Votes: 281 (Vote Outperform)Underperform Votes: 172 (Vote Underperform)Total Votes: 453MarketBeat's community ratings are surveys of what our community members think about Fresenius SE & Co KGaA and other stocks. Vote "Outperform" if you believe FRE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FRE will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/26/2019 by MarketBeat.com StaffFeatured Article: Day Trading - Risk Worth the Reward?